Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
January 20, 2020
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
Study links common immune cell to failure of checkpoint inhibitors in lung cancer
New research suggests how to better predict which patients will respond to immunotherapy
'Keeping these out of the hands of adolescents is critical'
Fred Hutch lung cancer expert testifies as Washington state weighs flavored vaping ban
New program to fast-track lung cancer research from lab to clinic
Patient-focused science at the heart of $13M National Cancer Institute grant
Could a simple blood test replace the invasive tissue biopsy?
Answer: It’s complicated …
Fred Hutch hosts a rising star in Seattle sports
All-Star right fielder Mitch Haniger and wife, Amanda, tour labs
A blood test for lung cancer
From the Houghton Laboratory, Clinical Research Division
A smoky immune response in lung cancer patients
From the Houghton lab, Clinical Research Division
The tumor microenvironment: How cancer fools healthy neighboring cells
‘Tumor microenvironment’ research underscores why we need cancer immunotherapy — and how to make it work for more patients
Good News: Bezos family funding accelerates glioma immunotherapy research
Celebrating faculty and staff achievements
Understand the immune response before altering it
From the Houghton and MacPherson Labs (Clinical Research and Human Biology Divisions)
Good News: Malik and Bloom win ASM awards; pilot project funded by Bezos family aims to create personalized anticancer vaccines
Celebrating faculty and staff achievements
Inaugural 'Oncology Summit' addresses academic-industry partnerships
Fred Hutch, Merck co-host inaugural ‘Oncology Summit’ to capture non-profit and for-profit outlooks on cancer care
Pulmonologist Houghton joins Center
McGarry Houghton seeks answers to lung cancer's molecular basis, epidemiology